Daniel L. Ripley serves as Executive at Conatus Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Daniel L. Ripley has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 14, 2018 involved receiving (via award) 1,861 shares valued at $5.9K.
Daniel L. Ripley currently holds 32,431 shares of Conatus Pharmaceuticals Inc. (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel L. Ripley has been a net neutral trader of CNAT stock. They have purchased $0 and sold $0 worth of shares.
Daniel L. Ripley's most recent insider trade was on Nov 14, 2018, when they sold 1,861 shares at $3.15 per share.
Get notified when new Form 4 filings are submitted
| $3.31 |
| Discretionary |
| Nov 14, 2017 | CNAT | $2.8K | Award | 818 | $3.48 | Discretionary |
| May 12, 2017 | CNAT | $1.3K | Award | 761 | $1.70 | Discretionary |